BSECompany Update1d ago · 23 Oct 2026, 08:24 pm

Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026

Strides Pharma Science Ltd · 532531

✦ AI SummaryResults

Strides Pharma Science Ltd has scheduled an Earnings Call for investors/analysts to discuss its Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

dd05ad4f-b9ee-4b50-9b3b-1996411809ad.pdf

pdf

Download →
View document text
October 23, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051. Dalal Street, Mumbai – 400 001. Symbol: STAR Scrip Code: 532531 Dear Madam/ Sir, Sub: Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. This is to inform you that Company has scheduled an Earnings Call for investors/ analysts to discuss its Unaudited Financial Results for the quarter and half year ended September 30, 2026, as per the following details: Day and Date Time Meeting Type Scheduled for Friday, 10:00 Hrs (IST) Conference Call – Investors/ October 30, Group Meet Analyst Group 2026 Invitation for the said Earnings Call is enclosed for your information and records. Above information will also be made available on the Company’s website at www.strides.com. Thanks & Regards For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No. A30515 Encl: a/a Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com Strides Pharma Science Limited Invites you to interact with the senior management on Q2FY27 performance. Friday, October 30, 2026 10:00 am 4:30 am 12:30 am 12:30 pm IST GMT EDT HKT Participants from the management: Badree Komandur Vikesh Kumar Managing Director & Group CEO Group CFO Pre-register for the call Click here to pre-register and join without the operator Join through an operator using dial-in numbers: India Primary: USA: 18667462133 Singapore: 8001012045 +91 22 6280 1434 / +91 22 7115 8838 UK: 08081011573 Hong Kong: 800964448 For any query, please reach out to: investor-relations@strides.com